Shanghai GenTech Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 4/6
Shanghai GenTech has a total shareholder equity of CN¥3.5B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 36.7%. Its total assets and total liabilities are CN¥9.3B and CN¥5.8B respectively. Shanghai GenTech's EBIT is CN¥611.7M making its interest coverage ratio -1020.4. It has cash and short-term investments of CN¥1.1B.
Wichtige Informationen
36.7%
Verhältnis von Schulden zu Eigenkapital
CN¥1.28b
Verschuldung
Zinsdeckungsgrad | -1020.4x |
Bargeld | CN¥1.10b |
Eigenkapital | CN¥3.49b |
Gesamtverbindlichkeiten | CN¥5.82b |
Gesamtvermögen | CN¥9.31b |
Jüngste Berichte zur Finanzlage
Recent updates
Shanghai GenTech Co., Ltd. (SHSE:688596) Stock Rockets 28% But Many Are Still Ignoring The Company
Oct 01Does Shanghai GenTech (SHSE:688596) Have A Healthy Balance Sheet?
Jul 29Sentiment Still Eluding Shanghai GenTech Co., Ltd. (SHSE:688596)
Jun 26Do Shanghai GenTech's (SHSE:688596) Earnings Warrant Your Attention?
May 24Shanghai GenTech's (SHSE:688596) Profits May Not Reveal Underlying Issues
May 06Returns On Capital At Shanghai GenTech (SHSE:688596) Have Stalled
Mar 28A Piece Of The Puzzle Missing From Shanghai GenTech Co., Ltd.'s (SHSE:688596) 26% Share Price Climb
Mar 03Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 688596's short term assets (CN¥7.2B) exceed its short term liabilities (CN¥5.2B).
Langfristige Verbindlichkeiten: 688596's short term assets (CN¥7.2B) exceed its long term liabilities (CN¥577.6M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 688596's net debt to equity ratio (5.1%) is considered satisfactory.
Schulden abbauen: 688596's debt to equity ratio has increased from 27.1% to 36.7% over the past 5 years.
Schuldendeckung: 688596's operating cash flow is negative, therefore debt is not well covered.
Zinsdeckung: 688596 earns more interest than it pays, so coverage of interest payments is not a concern.